Effect of Medical Marijuana on Neurocognition and Escalation of Use
Status:
Active, not recruiting
Trial end date:
2022-03-31
Target enrollment:
Participant gender:
Summary
This study will use a randomized controlled design to test whether patients who use medical
marijuana, compared to a waitlist control group, experience a change in health outcomes
(relief of symptoms, or adverse health outcomes such as new-onset symptoms of cannabis use
disorders, neurocognitive impairments) or brain-based changes.